Physician profile
Brian B Gilmer
NPI 1013172535
$204,153.63
in general payments reported to CMS, 2019-2025
23 companies · $89K in 2025
The $89K reported for 2025 was more than what 97% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,724 · 2020: $23K · 2021: $16K · 2022: $29K · 2023: $18K · 2024: $24K · 2025: $89K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $90K · Travel and Lodging: $21K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $3,543 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $90,257.02 |
| Travel and Lodging | $20,812.48 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,494.42 |
| Food and Beverage | $3,543.05 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,950.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Miach Orthopaedics, INC. | $95,127.26 | 2024-2025 | |
| Arthrex, INC. | $84,570.23 | 2019-2025 | |
| Linvatec Corporation | $15,811.42 | 2025 | Infinity Knee System, Livatec Knee Preservation System, Biobrace 23mm |
| Sequoia Surgical, INC. | $3,615.83 | 2019-2020 | |
| Evolution Surgical, INC | $1,487.85 | 2022-2024 | |
| Cornerstone Medical Associates, INC. | $1,200.00 | 2022 | |
| Stryker Corporation | $1,172.57 | 2022-2023 | Mako, Triathlon |
| Medacta USA, INC. | $294.41 | 2025 | Gmk Sphere |
| Trice Medical, INC. | $200.00 | 2019 | |
| Depuy Synthes Sales INC. | $146.91 | 2019-2023 | Velys |
| Abanza INC. | $116.75 | 2025 | Washercap Fixation System 10mm, Washercap Mini Fixation System 4.5mm |
| Smith+Nephew, INC. | $73.53 | 2019-2023 | Real Intelligence |
| Gemini Mountain Medical, LLC | $61.82 | 2024 | |
| Moximed, INC | $40.85 | 2025 | Misha Knee System, Small, Left |
| Bioventus LLC | $39.81 | 2023-2025 | Durolane, Exogen Ultrasound Bone Healing System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcuro Medical INC | $34.87 | 2023 | Superball |
| Amgen INC. | $30.00 | 2024 | Krystexxa |
| Vertex Pharmaceuticals Incorporated | $28.79 | 2025 | |
| Goode Surgical INC | $25.90 | 2025 | |
| Sanofi-Aventis U.S. LLC | $21.85 | 2023 | |
| Siemens Medical Solutions USA, INC. | $20.64 | 2019 | |
| Kci USA, INC. | $16.20 | 2022 | |
| Medical Device Business Services, INC. | $16.14 | 2023 | Velys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Gilmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.